Why Choose Us?
MyFILLER
My Filler is a special line of monophasic cross-linked
and non-cross linked hyaluronic acid dermal fillers
Dual Link Technology
A special formulation which takes advantage of both cross linked and non-cross linked technology to give practitioners and patients the optimum benefit of both in one amazing product.
The special line of fillers using DUAL Link Technology will give instant effect due to the non-cross linked and a long lasting result from the cross linked ensuring that patients are happy with their immediate results and saving the practitioner time by preventing the need for retouches.
Trio Technology
My Filler products are based on TRIO Technology where a specific HA molecular weight at different BDDE cross-linking rates and different hyaluronic acid concentrations are combined in a special production environment and specific manufacturing procedures for each type of dermal filler.
This complex formulation can be used to create all desired aesthetic facial outcomes.


Why Choose Us?
Revitalize
Revitalize is a complete line of professional
mesotherapy serums Revitalize is a state-of-the-art, compact range that is a sterile topical cosmetic for professional use. Revitalize range is versatile and has eight special serums. They are able to cover 99% of any cosmetic treatments with amazing results.
For additional information, please visit the Revitalize page and see the treatment protocols.


Why Choose Us?
A NEW GENERATION OF CROSS-LINKED HYALURONIC ACID FILLERS FOR THE TREATMENT OF SKIN BLEMISHES
EVRYÀL Cross-linked is a sterile, highly tolerated, viscoelastic filler made with cross-linked hyaluronic acid, ideal for subcutaneous applications.
EVRYÀL Cross-linked helps increase the volume of the dermo-epidermal tissue thanks to the natural ability of hydrophilic hyaluronic acid molecules to attract a moderate amount of water molecules and bond with them. This allows the integration of the intercellular matrix, whilst filling intradermal spaces and making the tissues firmer.
The cross-linked hyaluronic acid contained in the product makes this filling effect longer lasting and more stable. In fact, unlike linear hyaluronic acid, the skin slowly absorbs EVRYÀL Cross-linked in 6 to 8 months, looking more natural for longer. In addition to safety, BDDE – the cross-linking agent – provides effective results, thereby meeting market requirements.
EVRYÀL Cross-linked is a CE 0373 injectable, apyrogenic, resorbable medical device made with cross-linked hyaluronic acid created from non-animal sourced bacterial bio-fermentation.
It is a colourless monophasic gel contained in a disposable pre-filled, ergonomic syringe with a Luer Lock adapter.
The syringe is equipped with a plastic support that makes it easy to handle. Its accurate graduation allows you to control and read the volume of injected product.
Electronic verifications carried out throughout the entire filler production and packaging process, based on the use of state of the art technology, ensure quality, purity, and safety. These production standards, together with the extremely low concentration of nucleic acids and protein, and the bacterial endoxin rate < 0.5 EU/ml (much lower than the limit established by the European Pharmacopoeia for injectable products) minimise any hypersensitivity reaction.

CLINICAL TRIALS
A preclinical trial conducted by ten specialists (dermatologists, plastic surgeons, and cosmetic physicians) on 145 patients (women with a mean age of 50 years) over the course of one year has shown an excellent durability of the product. The graph n. 1 shows the duration of the treatment with the three dosages. The satisfaction questionnaires filled out by the specialists involved in the study showed an average satisfaction index (ASI) of 8/10 for both patients and physicians. The parameters taken into the consideration in the questionnaire were the malleability and tolerability of the product, its immediate effect, pain during the treatment (which resulted to be non-existent or tolerable), and the absence of oedema (graph n. 2).
RESULTS
Three different dosages allow for the treatment of any area of the face, reducing any type of wrinkle (fine to deep), reshaping the face contour and lips, and hydrating the skin in depth.
The result is very natural and immediately visible. EVRYÀL Cross-linked has an immediate lifting effect, thanks to its intrinsic viscoelastic and hydrophilic properties, which help recreate the desired volume.
EVRYÀL Cross-linked is injected subcutaneously to eliminate or at least reduce both superficial and deep wrinkles and increase soft tissue volume (lips, cheekbones, cheeks) for face countouring or reconstructive procedures (depressed scars, acne or chicken pox outcomes, facial asymmetry and atrophy, non-surgical rhinoplasty). This allows for safe, long-lasting results, considering that resorption occurs gradually over 6 to 8 months from treatment. The treatment can be safely repeated once the filling effects are significantly attenuated.
Ease of use and intrinsic safety facilitate the physician performing the treatment. After thorough cleansing and disinfection of the skin, a few microinjections in the areas to be treated is all it takes. The treatment is well tolerated and not painful.